Vitamin D and resveratrol in sarcopenic obesity: a systematic review highlighting the gap in phenotype-defined randomized controlled trials
Abstract
Background: Sarcopenic obesity (SO) is an inflammatory-metabolic condition characterized by the coexistence of excess adiposity and impaired skeletal muscle mass and function. Vitamin D and resveratrol modulate regulatory pathways implicated in SO pathophysiology, including NF-κB signaling, PGC-1α, mitochondrial regulation, and redox balance. Whether this mechanistic rationale has translated into phenotype-defined randomized clinical trials remains unclear.
Methods: We conducted a systematic dual-track search across PubMed, Scopus, and Web of Science to identify randomized controlled trials (RCTs) evaluating isolated vitamin D or resveratrol supplementation in adults with explicitly defined sarcopenic obesity or meeting implicit SO phenotype criteria, defined as the concurrent presence of adiposity and objective muscle impairment at baseline. Trials lacking confirmation of both components at enrollment were excluded. Risk of bias was assessed using Cochrane RoB 2.0.
Results: The search retrieved five records (PubMed n = 5; Scopus n = 0; Web of Science n = 0). Following full-text assessment, none met eligibility criteria requiring baseline confirmation of both adiposity and sarcopenia together with isolated vitamin D or resveratrol supplementation (n = 0). Retrieved RCTs in related populations did not simultaneously require adiposity and muscle impairment as enrollment criteria. As a result, no phenotype-defined interventional evidence specific to sarcopenic obesity was…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Effectiveness of Bisphosphonates and Denosumab on Risk of Vertebral Fractures in Prostate Cancer Patients Under Androgen Deprivation Therapies: A Real-World Prospective Study
- Osteoporosis-related fractures after spinal cord injury: a retrospective study from Brazil
- Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men
- Lack of Association between Vitamin D Insufficiency and Cardiovascular or Fracture Risk: A UK Biobank Study
- Muscle strength and body composition are clinical indicators of osteoporosis
- Incidence of bone protection and associated fragility injuries in patients with proximal femur fractures
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.